Glenmark Pharmaceuticals

Chennai: Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp, on Wednesday announced launch of nasal spray to treat adult Covid-19 patients.According to…

Chennai: Pharma major Glenmark Pharmaceuticals Limited on Tuesday announced the launch of Rufinamide tablets, 200 mg and 400 mg, a therapeutic equivalent of Banzel tablets, 200 mg and 400 mg of Eisai, Inc.In a statement issued Glenmark…

Chennai: Pharma major Glenmark Pharmaceuticals Limited on Monday said it has received the final approval from the United States Food & Drug Administration (USFDA) for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled…

Chennai:  Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis, in India.Glenmark has been the first to launch the branded…

Mumbai: Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate Covid-19 cases after it received the Indian drug regulator's approval.It will be available under the brand name FabiFlu…

New Delhi: Glenmark Pharmaceuticals said on Tuesday that it has initiated phase - three clinical trials on antiviral Favipiravir for COVID-19 patients in India.COVID-19 patients from over 10 leading government and private hospitals in…